We are live on ! Find out more
TECH icon

Bio-Techne

281 hedge funds and large institutions have $3.7B invested in Bio-Techne in 2016 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 100 increasing their positions, 106 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

385.97% more ownership

Funds ownership: 0%385.97% (+386%)

6% less repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 106

4% less funds holding

Funds holding: 293281 (-12)

5% less capital invested

Capital invested by funds: $3.91B → $3.7B (-$204M)

26% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 31

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
281
Holders Change
-12
Holders Change %
-4.1%
% of All Funds
7.03%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
23
Increased
100
Reduced
106
Closed
31
Calls
Puts
Net Calls
Net Calls Change

TECH Hedge Fund Activity: Q4 2016 in Review

281 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q4 2016, worth a combined $3.7B — down 5.2% from $3.91B a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of TECH and 23 opened new positions — a net loss of 8 holders — while 106 trimmed existing stakes and 100 added.

The largest buyer was OppenheimerFunds, opening a new position worth an estimated $23.3M. The largest seller was First Trust Advisors, cutting an estimated $16.5M.

  • 281 institutional investors held Bio-Techne (TECH) as of Q4 2016, down from 293 in Q3 2016.
  • Funds reported $3.7B of Bio-Techne stock for Q4 2016, down 5.2% quarter-over-quarter.
  • 23 funds opened new Bio-Techne positions in Q4 2016 and 31 closed out, a net change of -8 holders.
  • The largest Bio-Techne buyer in Q4 2016 was OppenheimerFunds, an estimated $23.3M added.
  • The largest Bio-Techne seller in Q4 2016 was First Trust Advisors, an estimated $16.5M sold.

Based on aggregated 13F filings for Q4 2016.